Company: INDP
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001641172-25-023333
Chunk: 35

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 1
Chunk 35
---
 common stock, net of issuance costs 
     505  
     5  
     38,059  
     -  
     38,064 
  
    Net loss 
     -  
     -  
     -  
     (4,015,267) 
     (4,015,267)
  
    Balance, June 30, 2024 
     305,462  
    $3,054  
    $59,402,254  
    $(53,239,100) 
    $6,166,208 

    Balance, January 1, 2025 
     428,799  
    $4,288  
    $64,379,770  
    $(60,439,183) 
    $3,944,875 

    Stock-based compensation 
     -  
     -  
     240,891  
     -  
     240,891 
  
    Issuance of shares of common stock and warrants, net of issuance costs (Note 6b) 
     75,335  
     754  
     1,985,990  
     -  
     1,986,744 
  
    Issuance of shares of common stock, net of issuance costs (Note 6c) 
     57,328  
     573  
     1,159,078  
     -  
     1,159,651 
  
    Issuance of commitment shares (Note 6c) 
     10,927  
     109  
     (109) 
     -  
     - 
  
    Net loss 
     -  
     -  
     -  
     (4,532,430) 
     (4,532,430)

    Balance, March 31, 2025 
     572,389  
    $5,724  
    $67,765,620  
    $(64,971,613) 
    $2,799,731 
  
    Balance 
     572,389  
    $5,724  
    $67,765,620  
    $(64,971,613) 
    $2,799,731 

    Issuance of shares of common